ent-16alpha,17-Dihydroxyatisan-3-oneCAS# 112523-91-8 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 112523-91-8 | SDF | Download SDF |
| PubChem ID | 453152 | Appearance | Powder |
| Formula | C20H32O3 | M.Wt | 320.5 |
| Type of Compound | Diterpenoids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| SMILES | CC1(C2CCC34CCC(CC3C2(CCC1=O)C)C(C4)(CO)O)C | ||
| Standard InChIKey | GFMRAAZMCOCUCY-ALCQSMKISA-N | ||
| Standard InChI | InChI=1S/C20H32O3/c1-17(2)14-5-9-19-8-4-13(20(23,11-19)12-21)10-15(19)18(14,3)7-6-16(17)22/h13-15,21,23H,4-12H2,1-3H3/t13-,14-,15+,18-,19-,20-/m1/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | 1. ent-16alpha,17-Dihydroxyatisan-3-one and ent-16alpha,17-dihydroxykauran-3-one have apoptosis induction activities on L5178 human MDR1 gene-transfected mouse lymphoma cells. |
| Targets | P-gp |
ent-16alpha,17-Dihydroxyatisan-3-one Dilution Calculator
ent-16alpha,17-Dihydroxyatisan-3-one Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 3.1201 mL | 15.6006 mL | 31.2012 mL | 62.4025 mL | 78.0031 mL |
| 5 mM | 0.624 mL | 3.1201 mL | 6.2402 mL | 12.4805 mL | 15.6006 mL |
| 10 mM | 0.312 mL | 1.5601 mL | 3.1201 mL | 6.2402 mL | 7.8003 mL |
| 50 mM | 0.0624 mL | 0.312 mL | 0.624 mL | 1.248 mL | 1.5601 mL |
| 100 mM | 0.0312 mL | 0.156 mL | 0.312 mL | 0.624 mL | 0.78 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- CI994 (Tacedinaline)
Catalog No.:BCC2159
CAS No.:112522-64-2
- Citrusinol
Catalog No.:BCN8083
CAS No.:112516-43-5
- Tubuloside A
Catalog No.:BCN2806
CAS No.:112516-05-9
- Neolinine
Catalog No.:BCN6564
CAS No.:112515-37-4
- Isoabsouline
Catalog No.:BCN1955
CAS No.:112513-34-5
- Absouline
Catalog No.:BCN1954
CAS No.:112513-33-4
- Picrasidine S
Catalog No.:BCN6006
CAS No.:112503-87-4
- Aristolactam FI
Catalog No.:BCN6005
CAS No.:112501-42-5
- 6-Aldehydo-isoophiopogonone A
Catalog No.:BCN6629
CAS No.:112500-90-0
- 5-Aminoisoquinoline
Catalog No.:BCC8736
CAS No.:1125-60-6
- 4,4-Pentamethylenepiperidine hydrochloride
Catalog No.:BCC6059
CAS No.:1125-01-5
- H-Glu(OcHex)-OH
Catalog No.:BCC2929
CAS No.:112471-82-6
- Pioglitazone HCl
Catalog No.:BCC2278
CAS No.:112529-15-4
- 4-O-Methylepisappanol
Catalog No.:BCN3674
CAS No.:112529-37-0
- Mps1-IN-1
Catalog No.:BCC5590
CAS No.:1125593-20-5
- A 804598
Catalog No.:BCC6198
CAS No.:1125758-85-1
- SKLB610
Catalog No.:BCC3647
CAS No.:1125780-41-7
- 4-Allylpyrocatechol
Catalog No.:BCN6009
CAS No.:1126-61-0
- Iso-mogroside V
Catalog No.:BCN3047
CAS No.:1126032-65-2
- Dicyclanil
Catalog No.:BCC8938
CAS No.:112636-83-6
- U-73122
Catalog No.:BCC5199
CAS No.:112648-68-7
- Garcinone E
Catalog No.:BCN3604
CAS No.:112649-21-5
- BR-Xanthone A
Catalog No.:BCN6007
CAS No.:112649-48-6
- 1,7-Dihydroxyacridone
Catalog No.:BCN7275
CAS No.:112649-95-3
Multidrug resistance modulation and apoptosis induction of cancer cells by terpenic compounds isolated from Euphorbia species.[Pubmed:20032393]
Anticancer Res. 2009 Nov;29(11):4467-72.
BACKGROUND: One of the most promising strategies to overcome multidrug resistance (MDR) is to use compounds that can modulate P-glycoprotein and restore the cytotoxicity of anticancer drugs. Furthermore, the search for compounds that regulate and overcome apoptosis deficiency of cancer cells is also of great therapeutic importance. MATERIALS AND METHODS: Seven known pentacyclic triterpenes and one steroid were isolated from Euphorbia lagascae methanolic extracts and identified by physical and spectroscopic methods. These compounds, together with eleven terpenoids previously isolated from Euphorbia lagascae and E. tuckeyana were tested for their MDR-reversing and/or apoptosis induction activities by flow cytometry on L5178 human MDR1 gene-transfected mouse lymphoma cells. RESULTS: Four taraxastane-type triterpenes: 21alpha-hydroxytaraxasterol, 21alpha-hydroxytaraxasterol acetate, 3beta,30-dihydroxy-20(21)-taraxastene and 3beta-hydroxy-20-taraxasten-30-al, and two steroids: stigmastane-3,6-dione and ergosterol peroxide exhibited a significant MDR-Pgp modulation activity. Some aspects of structure-activity relationships are discussed. Regarding apoptosis induction, the most significant results were obtained for the polycyclic diterpenes ent-16alpha,17-dihydroxykauran-3-one and ent-16alpha,17-Dihydroxyatisan-3-one.
